메뉴 건너뛰기




Volumn 164, Issue 7, 2001, Pages 1112-1113

Hepatotoxicity from rifampin plus pyrazinamide: Lessons for policymakers and messages for care providers

Author keywords

[No Author keywords available]

Indexed keywords

ISONIAZID; PYRAZINAMIDE; RIFAMPICIN; RIFAPENTINE;

EID: 0035482544     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.164.7.2109052     Document Type: Short Survey
Times cited : (42)

References (17)
  • 1
    • 0035482828 scopus 로고    scopus 로고
    • Update: Fatal and severe liver injuries associated with rifampin and pyrazinamide for latent tuberculosis infection, and revisions in the American Thoracic Society/CDC recommendations - United States, 2001
    • (2001) Am J Respir Crit Care Med , vol.164 , pp. 1319-1320
  • 4
    • 0034091974 scopus 로고    scopus 로고
    • Targeted tuberculin testing and treatment of latent tuberculosis infection
    • (2000) Am J Respir Crit Care Med , vol.161 , Issue.SUPPL.
  • 12
    • 0018840438 scopus 로고
    • Side effects of drug regimens used in short-course chemotherapy for pulmonary tuberculosis. A controlled clinical study
    • (1980) Tubercle , vol.61 , pp. 41-49
    • Zierski, M.1    Bek, E.2
  • 17
    • 0027369140 scopus 로고
    • Fatal isoniazid-induced hepatitis. Its risk during chemoprophylaxis
    • (1993) West J Med , vol.159 , pp. 560-564
    • Saltpeter, S.R.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.